XML 75 R61.htm IDEA: XBRL DOCUMENT v3.22.4
Note 14 - Segment Information - Results of the Segments (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Jan. 02, 2021
Revenues $ 284,680 $ 203,875 $ 150,409
Cost of services 201,753 150,751 111,554
Gross profit 82,927 53,124 38,855
Selling, general and administrative 53,395 42,019 37,791
Depreciation and amortization of property and equipment 995 1,007 1,065
Amortization of acquired intangible assets 46 95 321
Remeasurement of acquisition-related contingent consideration (88) (1,713) 0
Gain on sale of assets (219) (2,420) 0
Operating income 28,798 14,136 (10,950)
Total assets 87,964 72,852 68,339
Property and equipment acquired 1,152 1,576 460
Operating income   14,136  
Write-off of receivables and professional fees incurred related to arbitration 0 0 8,397
Impairment of right of use assets and related costs 0 0 2,231
Specialty Health Care [Member]      
Revenues 159,448 98,495 60,481
Cost of services 111,543 73,177 47,116
Gross profit 47,905 25,318 13,365
Selling, general and administrative 27,661 19,491 15,601
Depreciation and amortization of property and equipment 426 373 319
Amortization of acquired intangible assets 0 0 0
Remeasurement of acquisition-related contingent consideration 0 0  
Gain on sale of assets 0 0  
Operating income 19,818   (2,555)
Total assets 34,062 32,809 19,141
Property and equipment acquired 75 563 36
Operating income   5,454  
Write-off of receivables and professional fees incurred related to arbitration     0
Impairment of right of use assets and related costs     0
Engineering [Member]      
Revenues 85,937 66,172 57,715
Cost of services 64,218 50,109 41,227
Gross profit 21,719 16,063 16,488
Selling, general and administrative 17,272 14,210 13,021
Depreciation and amortization of property and equipment 455 521 638
Amortization of acquired intangible assets 0 95 321
Remeasurement of acquisition-related contingent consideration (88) (1,713)  
Gain on sale of assets (219) (2,420)  
Operating income 4,299   (5,889)
Total assets 33,447 28,343 33,782
Property and equipment acquired 657 481 26
Operating income   5,370  
Write-off of receivables and professional fees incurred related to arbitration     8,397
Impairment of right of use assets and related costs     0
Life Sciences and IT [Member]      
Revenues 39,295 39,208 32,213
Cost of services 25,992 27,465 23,211
Gross profit 13,303 11,743 9,002
Selling, general and administrative 8,462 8,318 9,169
Depreciation and amortization of property and equipment 114 113 108
Amortization of acquired intangible assets 46 0 0
Remeasurement of acquisition-related contingent consideration 0 0  
Gain on sale of assets 0 0  
Operating income 4,681   (275)
Total assets 15,778 8,676 7,498
Property and equipment acquired 124 173 48
Operating income   3,312  
Write-off of receivables and professional fees incurred related to arbitration     0
Impairment of right of use assets and related costs     0
Corporate Segment [Member]      
Revenues 0 0 0
Cost of services 0 0 0
Gross profit 0 0 0
Selling, general and administrative 0 0 0
Depreciation and amortization of property and equipment 0 0 0
Amortization of acquired intangible assets 0 0 0
Remeasurement of acquisition-related contingent consideration 0 0  
Gain on sale of assets 0 0  
Operating income 0   (2,231)
Total assets 4,677 3,024 7,918
Property and equipment acquired $ 296 359 350
Operating income   $ 0  
Write-off of receivables and professional fees incurred related to arbitration     0
Impairment of right of use assets and related costs     $ 2,231